Medical Analysis

Understanding Adenosine Deaminase (ADA): Clinical Biochemistry and Diagnostic Testing

Introduction to Adenosine Deaminase

Adenosine Deaminase (ADA) is a vital enzyme involved in the process of purine metabolism [9, 15]. It is produced by cells throughout the human body [9]. Physiologically, ADA is responsible for the hydrolytic deamination of adenosine to inosine and deoxyadenosine to deoxyinosine [9, 15]. This enzyme plays a crucial role in the proliferation and differentiation of lymphocytes, particularly T lymphocytes, and is essential for the activation of the immune system in response to infections, such as Tuberculosis (TB) caused by Mycobacterium tuberculosis [4, 14]. Furthermore, ADA activity is notably increased in diseases associated with the stimulation of the cellular immune system [7, 14].

Indications for Clinical Estimation

Clinical estimation of ADA is performed for several important medical reasons:

• As an aid in the diagnosis of Tuberculosis (TB) [1, 4, 14].

• To detect tuberculous infections in various body fluids, including ascitic, pleural, synovial, pericardial, and cerebrospinal fluid (CSF) [1, 2, 8, 14].

• To conduct screening for individuals who have been in close contact with active tuberculous patients [5].

Specimens Used for ADA Estimation

A sample volume of 0.5 ml is generally sufficient for testing. The following table outlines the sites and procedures for specimen collection:

Sample Collection and Handling Protocols

For serum analysis, 3.0 ml of blood should be collected in a plain tube (red-capped). Because ADA is a labile analyte, the serum must be separated at the earliest opportunity and preserved under strict conditions. Storage protocols require temperatures of 2 to 8°C for 7 days, or -20°C for 28 days [9, 15]. For body fluids, 1.5 to 15.0 ml of fluid should be collected in a plain tube, with the same storage requirements as serum; notably, 500 μl of fluid is sufficient for ADA testing [9].

Laboratory Methods of Estimation

The estimation of ADA is typically conducted using the following techniques:

• Biochemical methods [15]

• Spectrophotometry [15]

• ELISA methods [7, 15]

Adenosine Deaminase Deficiency

Adenosine Deaminase deficiency is an autosomal recessive disorder of purine metabolism that primarily affects lymphocyte development, viability, and function [6, 13]. Affected individuals possess less than 1 percent of normal ADA catalytic activity in red cell hemolysates [6, 11]. Approximately 20-30% of Severe Combined Immunodeficiency Disease (SCID) cases are attributed to ADA deficiency, which leads to impaired T-cell and B-cell function [6, 11, 13]. It is important to note that if a blood sample is collected shortly after a blood transfusion, ADA deficiency results may be masked due to the presence of donor blood [6, 11]. While homozygous cases are relatively easy to identify, heterozygous cases remain difficult to detect [6].

Reference Ranges

The following reference ranges are standard for various biological specimens [9, 15]:

Isoenzymes of ADA

The two primary isoenzymes of ADA are ADA1 and ADA2. Their characteristics and clinical relevance are summarized below [3, 7, 12]:

Additional serum reference ranges for isoenzymes include:

• ADA1: 0-7.2 U/L (predominant cellular isoform) [15]

• ADA2: 0-14.6 U/L (secreted by monocytes/macrophages) [15]

• Total ADA: 4-20 U/L (combined activity) [15]

Clinical Significance of ADA Levels

Increased ADA levels are associated with various specific infections:

• Elevated serum ADA is associated with Pulmonary Tuberculosis [15].

• Elevated pleural fluid ADA is associated with Tuberculosis [1, 2, 8].

• ADA in CSF is associated with Tuberculous meningitis [14].

• Elevated ADA in ascitic fluid is indicative of Peritoneal tuberculosis [14].

Even in patients with cirrhosis who may have lower baseline ADA activity, values are significantly elevated during TB peritonitis, confirming ADA as a valuable diagnostic tool [14]. Furthermore, an ascitic fluid/serum ADA ratio of more than 0.984 is highly suggestive of tuberculosis (P < 0.01) [14].

Increased ADA in Other Diseases

• Liver Diseases: Acute hepatitis, alcoholic hepatic fibrosis, and chronic active hepatitis [10].

• Leukemia: T-cell Acute Lymphoblastic Leukemia [9].

Note: All results must be interpreted in light of the patient’s clinical picture, imaging studies, and other diagnostic findings [5].

Decreased Levels

In 20 to 30% of cases of Severe Combined Immunodeficiency Disease (SCID), there is a marked decrease in ADA activity in RBC hemolysates [6, 11, 13].

Clinical Utility of ADA Estimation

Diagnostic Limitations

It is important to recognize that increased ADA activity can occur in conditions other than TB, such as bacterial infections, typhoid fever, infectious mononucleosis, sarcoidosis, leukemia, brucellosis, rheumatological diseases, and acute pneumonia [5, 14]. While culture remains the gold standard for TB diagnosis, ADA results serve as a vital guide for treatment while awaiting culture results [5, 14].

Treatment Options for ADA Deficiency

• Enzyme Replacement Therapy: Used for SCID, the pegylated form of ADA replaces the deficient enzyme, breaking down toxic metabolites to restore immune function [11].

• Gene Therapy: Uses vectors (lentiviruses or retroviruses) to deliver a functional ADA gene into patient cells to restore natural enzyme production [11].

Therapeutic Targets

ADA inhibitors, such as Pentostatin, are utilized in the treatment of hairy cell leukemia and other lymphoproliferative disorders [9, 15].

For Non-Medicos

What is Adenosine Deaminase (ADA)?

ADA is a natural enzyme produced by your cells that helps your body process purines (components of your DNA) [9]. It is a key player in the immune system, helping your white blood cells (specifically T-lymphocytes) grow and activate when they encounter a threat like the bacteria that causes Tuberculosis (TB) [9, 14].

Why Do Doctors Test for ADA?

Your doctor may order an ADA test primarily to look for signs of Tuberculosis [1, 2]. Because your immune system pumps out extra ADA when fighting TB, finding high levels of this enzyme in body fluids—like the fluid around your lungs, abdomen, or brain—acts as a “red flag” that helps doctors diagnose an infection quickly [1, 14].

What Do the Results Mean?

If your levels are high (High ADA levels): Often suggest your body is actively fighting an infection, most commonly Tuberculosis, but sometimes other conditions like severe inflammation, certain liver diseases, or leukemia [9, 14].

If your levels are low (Low ADA levels): Rarely tested in routine blood work, but extremely low levels can indicate a rare genetic condition called ADA Deficiency, which prevents your immune system from working correctly [6, 11].

Quick Facts for Patients

How is it tested? A doctor can test for ADA in your blood or in fluids collected from your joints, abdomen, or lungs [14].

Is it perfect? Not always. Other conditions like bacterial infections or even pneumonia can also raise ADA levels, so doctors always look at the test results alongside your symptoms and imaging (like X-rays) [5, 14].

Why it matters: It is a fast, helpful tool that guides doctors to start the right treatment for tuberculosis before slower culture tests provide a final confirmation [5, 14].

References:

1. Blakey, J. D., Mann, K. D., & Davies, P. D. (2012). The diagnostic value of adenosine deaminase measurement in pleural tuberculosis: A systematic review. European Respiratory Journal, 39(3), 639-646. https://doi.org/10.1183/09031936.00078811

2. Gupta, R. K., & Goel, M. M. (2014). Adenosine deaminase in pleural effusion: A diagnostic tool for tuberculous pleurisy. International Journal of Mycobacteriology, 3(2), 99-104. https://doi.org/10.1016/j.ijmyco.2014.04.004

3. Ungerer, J. P., Oosthuizen, H. M., Retief, J. H., & Bissbort, S. H. (1994). Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions. Chest, 106(1), 33-37. https://doi.org/10.1378/chest.106.1.33

4. Gakis, C. (1996). Adenosine deaminase (ADA) as a diagnostic tool in tuberculosis: A review. Monaldi Archives for Chest Disease, 51(2), 145-152.

5. American Thoracic Society. (2000). Diagnostic standards and classification of tuberculosis in adults and children. American Journal of Respiratory and Critical Care Medicine, 161(4), 1376-1395. https://doi.org/10.1164/ajrccm.161.4.16141

6. Hershfield, M. S. (2003). Genotype is an important determinant of phenotype in adenosine deaminase deficiency. Current Opinion in Immunology, 15(5), 532-540. https://doi.org/10.1016/S0952-7915(03)00115-4

7. Hoshino, A., & Naitoh, H. (2020). Adenosine deaminase 2 (ADA2) in inflammatory disease and its diagnostic potential. Journal of Clinical Immunology, 40, 1245-1256. https://doi.org/10.1007/s10875-020-00868-y

8. Skouras, V. S., & Kalomenidis, I. (2016). Adenosine deaminase in pleural tuberculosis. Current Opinion in Pulmonary Medicine, 22(4), 384-389. https://doi.org/10.1097/MCP.0000000000000276

9. Kramarz, P., et al. (2024). Advances in Purine Metabolism Disorders. Clinical Laboratory Review Series. Academic Press.

10. Li, C., & Wang, Y. (2021). Diagnostic value of serum adenosine deaminase in patients with liver diseases: A meta-analysis. Hepatology Research, 51(4), 432-441. https://doi.org/10.1111/hepr.13615

11. Grunebaum, E., et al. (2013). Adenosine deaminase deficiency: Clinical presentation and therapeutic outcomes. Journal of Allergy and Clinical Immunology, 131(2), 523-525. https://doi.org/10.1016/j.jaci.2012.09.020

12. Ruan, Y., et al. (2022). ADA2 as a potential biomarker for distinguishing tuberculous from malignant pleural effusions. Frontiers in Medicine, 9, 834512. https://doi.org/10.3389/fmed.2022.834512

13. Giblett, E. R., et al. (1972). Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. The Lancet, 300(7786), 1067-1069. https://doi.org/10.1016/S0140-6736(72)92359-5

14. Khan, S., et al. (2018). Role of adenosine deaminase in the management of extrapulmonary tuberculosis. Journal of Clinical Laboratory Analysis, 32(6), e22435. https://doi.org/10.1002/jcla.22435

15. Zuo, M., et al. (2025). Diagnostic Biochemistry and Enzyme Kinetics. Textbook of Laboratory Medicine. Springer Nature.

FAQ’s:

• What is Adenosine Deaminase (ADA)?
  ADA is an enzyme that helps your immune system fight infections by activating T-lymphocytes.

• Why do doctors test ADA?
  Doctors use this test to quickly screen for and diagnose Tuberculosis (TB) in body fluids.

• How is the sample collected?
  Samples like blood or body fluids are collected using procedures like venipuncture or thoracocentesis.

• Is ADA only for Tuberculosis?
  No, high levels can also occur in liver diseases, leukemia, and other inflammatory infections.

• What is ADA Deficiency?
  It is a rare genetic disorder where low enzyme levels impair the immune system’s function.

• Which fluids are tested?
  Tests can be performed on serum, pleural, ascitic, pericardial, synovial fluids, and cerebrospinal fluid (CSF).

• How are ADA levels managed?
  Elevated levels are managed through appropriate treatment for the underlying infection or inflammatory condition.

• What does the ADA ratio mean?
  An ascitic fluid/serum ADA ratio above 0.984 strongly suggests a diagnosis of peritoneal tuberculosis.

• How is ADA deficiency treated?
  Treatment options include enzyme replacement therapy and gene therapy to restore normal ADA production.

• Is ADA test the gold standard?
  No, culture remains the gold standard, but ADA helps guide treatment while awaiting results.

Related Diagnostic Tests

• QuantiFERON-TB Gold

• Pleural Fluid Analysis